Evaluation of the antioxidant and anti-glication effects of the hexane extract from Piper auritum leaves in vitro and beneficial activity on oxidative stress and advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats

Molecules. 2012 Oct 9;17(10):11897-919. doi: 10.3390/molecules171011897.

Abstract

The aim of this study was to investigate the antioxidant activity of hexane extracts from leaves of Piper auritum (HS). Eight complementary in vitro test methods were used, including inhibition of DPPH· radicals, nitric oxide, superoxide anion, ion-chelating, ABTS, oxygen radical absorbance capacity, β-carotene bleaching and peroxy radical scavenging. The results indicated that HS possesses high antioxidant activity. To add to these finding we tested the effect against oxidative stress in liver, pancreas and kidney in diabetic rats. Low levels of SOD, CAT, GPx and GSH in diabetic rats were reverted to near normal values after treatment with HS. These results suggest that P. auritum prevents oxidative stress, acting as a suppressor of liver cell damage. Given the link between glycation and oxidation, we proposed that HS might possess significant in vitro antiglycation activity. Our data confirmed the inhibitory effect of HS on bovine serum albumin, serum glycosylated protein, glycation of LDL, and glycation hemoglobin. The effect of HS on diabetic renal damage was investigated using streptozotocin-induced diabetic rats. The oral administration of HS at a dose of 200 and 400 mg/kg body weight/day for 28 days significantly reduced advanced glycation endproduct (AGE) formation, elevated renal glucose and thiobarbituric acid-reactive substance levels in the kidneys of diabetic rats. This implies that HS would alleviate the oxidative stress under diabetes through the inhibition of lipid peroxidation. These findings indicate that oxidative stress is increased in the diabetic rat kidney and that HS can prevent renal damage associated with diabetes by attenuating the oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology*
  • Diabetes Mellitus, Experimental / complications
  • Diabetic Nephropathies / drug therapy
  • Diabetic Nephropathies / etiology
  • Diabetic Nephropathies / metabolism*
  • Free Radical Scavengers / pharmacology
  • Glycation End Products, Advanced / metabolism*
  • Glycosylation / drug effects
  • Hexanes
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / pharmacology
  • Iron Chelating Agents / pharmacology
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Oxidative Stress / drug effects*
  • Oxidoreductases / metabolism
  • Pancreas / drug effects
  • Pancreas / metabolism
  • Phenols / chemistry
  • Piper / chemistry*
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology*
  • Plant Leaves / chemistry
  • Rats
  • Thiobarbituric Acid Reactive Substances / metabolism

Substances

  • Antioxidants
  • Free Radical Scavengers
  • Glycation End Products, Advanced
  • Hexanes
  • Hypoglycemic Agents
  • Iron Chelating Agents
  • Phenols
  • Plant Extracts
  • Thiobarbituric Acid Reactive Substances
  • Oxidoreductases